{"id":398989,"date":"2022-09-29T14:26:11","date_gmt":"2022-09-29T14:26:11","guid":{"rendered":"https:\/\/teknomers.com\/es\/experto-califica-de-esperanzador-nuevo-farmaco-contra-el-alzheimer-esto-puede-ralentizar-significativamente-el-declive-de-los-pacientes\/"},"modified":"2022-09-29T14:26:12","modified_gmt":"2022-09-29T14:26:12","slug":"experto-califica-de-esperanzador-nuevo-farmaco-contra-el-alzheimer-esto-puede-ralentizar-significativamente-el-declive-de-los-pacientes","status":"publish","type":"post","link":"https:\/\/teknomers.com\/es\/experto-califica-de-esperanzador-nuevo-farmaco-contra-el-alzheimer-esto-puede-ralentizar-significativamente-el-declive-de-los-pacientes\/","title":{"rendered":"Experto califica de esperanzador nuevo f\u00e1rmaco contra el Alzheimer: &#8220;Esto puede ralentizar significativamente el declive de los pacientes&#8221;"},"content":{"rendered":"\n<p>El nuevo f\u00e1rmaco para el Alzheimer, lecanemab, que ralentiza significativamente el declive intelectual de los pacientes, es un avance particularmente importante, seg\u00fan el experto Sebastiaan Engelborghs.  \u201cEl medicamento est\u00e1 abordando los efectos de la enfermedad en un grado que nunca antes hab\u00edamos visto\u201d.  Sin embargo, eso no significa que estemos cerca de una p\u00edldora santificadora que suprime el Alzheimer.<br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.hln.be\/medisch\/expert-noemt-nieuw-alzheimermedicijn-hoopgevend-dit-kan-achteruitgang-van-patienten-aanzienlijk-vertragen~a7d6697a\/\" rel=\"nofollow noopener\" target=\"_blank\">ttn-es-3<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El nuevo f\u00e1rmaco para el Alzheimer, lecanemab, que ralentiza significativamente el declive intelectual de los pacientes, es un<\/p>\n","protected":false},"author":1,"featured_media":398990,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[20265,13078,110,23314,113043,155,1148,34911,36,480,709,149,107346,2588],"class_list":["post-398989","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-alzheimer","tag-califica","tag-contra","tag-declive","tag-esperanzador","tag-esto","tag-experto","tag-farmaco","tag-los","tag-nuevo","tag-pacientes","tag-puede","tag-ralentizar","tag-significativamente"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/398989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/comments?post=398989"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/398989\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media\/398990"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media?parent=398989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/categories?post=398989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/tags?post=398989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}